跳至主要内容
临床试验/NCT03701984
NCT03701984已完成4 期

The Effect of Intrauterine Lidocaine Infusion and Oral Tramadol on Pain During Diagnostic Office Hysteroscopy in Postmenopausal Women: Randomized Double-Blind Controlled Study

Cairo University1 个研究点 分布在 1 个国家目标入组 156 人开始时间: 2018年10月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
156
试验地点
1
主要终点
Pain perception during the procedure

研究概览

简要总结

The purpose of this study is to compare the effectiveness of Tramadol and intrauterine lidocaine infusion in reducing pain during outpatient diagnostic hysteroscopy in postmenopausal women.

详细描述

The purpose of this study is to compare the effectiveness of Tramadol and intrauterine lidocaine infusion in reducing pain during outpatient diagnostic hysteroscopy in postmenopausal women. Postmenopausal Women undergoing outpatient hysteroscopy in Cairo university will be divided into three groups, the first group will receive Tramadol 5mg 1 hour before the procedure, the second group will receive 20 ml lidocaine in 1000 ml normal saline infusion during the procedure, and the third will receive a placebo. A visual analog scale will assess pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

性别
Female
接受健康志愿者

入选标准

  • Menopausal patients with an indication for office hysteroscopy (postmenopausal bleeding or abnormal ultrasound findings)
  • Consent to the procedure

排除标准

  • Positive Chlamydia culture.
  • patients who have an Allergy to local anesthesia or tramadol.
  • A previous adverse reaction to any of the drugs used in the study.
  • Patients were receiving any form of analgesia or current use of monoamine oxidase inhibitors.
  • Nulliparous patients and patients with cervical pathology, retroverted uterus (detected by transvaginal ultrasound), and previous cervical surgery.
  • Patients who have severe vaginal bleeding.

研究组 & 干预措施

lidocaine infusion arm

Experimental

The lidocaine group will be administered a 1,000 ml distention medium containing 5 ml lidocaine per 250 ml (DEBOCAINE (LIDOCAINE) 2% 1 VIAL 50 ML, Sigma-Tec pharmaceutical Industry. Co. Egypt) and oral placebo similar to tramadol(given 1 hour before the procedure).

干预措施: Lidocaine (Drug)

tramadol arm

Active Comparator

will be administered with an oral tramadol tablet (Tramal®, Memphis, Giza, Egypt) 1 h before the procedure and with a 1,000 ml distention medium containing 5 ml serum physiologic per 250 ml.

干预措施: Tramadol (Drug)

placebo group

Placebo Comparator

will be administered with a 1,000 ml distention medium containing 5 ml serum physiologic per 250 ml and oral placebo(1 h before the procedure).

干预措施: placebo (Drug)

结局指标

主要结局

Pain perception during the procedure

时间窗: 10 minutes after starting the procedure.

The pain will be assessed using a visual analogue scale(VAS) after inserting the hysteroscope through the cervical canal.VAS of 0 indicates no pain and VAS of 10 indicates the worst possible experienced pain. The pain VAS is self-completed by the patients. The patients are asked to place a line perpendicular to the VAS line at the point that represents their pain intensity

次要结局

  • Pain perception after the procedure(10 minutes after the procedure.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Samy aly ashour

lecturer in obstetrics and gynecology

Cairo University

研究点 (1)

Loading locations...

相似试验